All issues > Volume 17(5); 1974

Original Article

J Korean Pediatr Soc. 1974;17(5):369-378. Published online May 31, 1974.

Clinical Studies on Cefamezin in Pediatric Field

Keun Soo Lee¹, Keun Chan Sohn¹, Choong Sik Kim¹, U1 Soon Park¹

¹

Abstract

Clinical studies on Cefamezin, a new Cephalosporin C derivative, were performed with the following results. 1. Cefamezin was intramuscularly administered in a daily dose of 40〜100 mg/kg to 50 children with various infections for 3 to 25 days. The therapeutic results were excellent in 37 patients, good in 7, fair in 5 and no response in 1. The effectiveness rate was 88% 2. No noticeable side effects were observed except frequent loose bowel movement in 3 cases and mild skin rash in 1 case. 3. Cefamezin was tried in various infections of prematurity and neonatal infant, and could be appraised as the first drug of choice in neonatal bacterial infections.

Keywords :